156 related articles for article (PubMed ID: 34131820)
1. ASO Author Reflections: Multimodality Treatment in Anaplastic Thyroid Cancer: Improving Survival Outcomes and Balancing Treatment Related Complications.
Jonker PKC; Sywak M
Ann Surg Oncol; 2021 Nov; 28(12):7531-7532. PubMed ID: 34131820
[No Abstract] [Full Text] [Related]
2. ASO Author Reflections: Applying the Lens of Equity to Anaplastic Thyroid Cancer Care.
Ginzberg SP; Gasior JA; Wachtel H
Ann Surg Oncol; 2023 Oct; 30(11):6799-6800. PubMed ID: 37523118
[No Abstract] [Full Text] [Related]
3. Multimodality treatment of anaplastic thyroid cancer with nearly resolved effect.
Tseng YT; Chang TC
J Formos Med Assoc; 2015 Sep; 114(9):897-8. PubMed ID: 24755268
[No Abstract] [Full Text] [Related]
4. Diagnosis and Management of Anaplastic Thyroid Cancer.
Chintakuntlawar AV; Foote RL; Kasperbauer JL; Bible KC
Endocrinol Metab Clin North Am; 2019 Mar; 48(1):269-284. PubMed ID: 30717908
[TBL] [Abstract][Full Text] [Related]
5. Anaplastic thyroid carcinoma: review of treatment protocols.
Tiedje V; Stuschke M; Weber F; Dralle H; Moss L; Führer D
Endocr Relat Cancer; 2018 Mar; 25(3):R153-R161. PubMed ID: 29295821
[TBL] [Abstract][Full Text] [Related]
6. Anaplastic thyroid carcinoma: Failure of conventional therapy but hope of targeted therapy.
Lennon P; Deady S; Healy ML; Toner M; Kinsella J; Timon CI; O'Neill JP
Head Neck; 2016 Apr; 38 Suppl 1():E1122-9. PubMed ID: 26879282
[TBL] [Abstract][Full Text] [Related]
7. Spanish consensus for the management of patients with anaplastic cell thyroid carcinoma.
Jiménez-Fonseca P; Gómez Saez JM; Santamaria Sandi J; Capdevila J; Navarro Gonzalez E; Zafon Llopis C; Ramón Y Cajal Asensio T; Riesco-Eizaguirre G; Grande E; Galofré JC
Clin Transl Oncol; 2017 Jan; 19(1):12-20. PubMed ID: 27048161
[TBL] [Abstract][Full Text] [Related]
8. Facilitating anaplastic thyroid cancer specialized treatment: A model for improving access to multidisciplinary care for patients with anaplastic thyroid cancer.
Cabanillas ME; Williams MD; Gunn GB; Weitzman SP; Burke L; Busaidy NL; Ying AK; Yiin YH; William WN; Lu C; Lai SY
Head Neck; 2017 Jul; 39(7):1291-1295. PubMed ID: 28452157
[TBL] [Abstract][Full Text] [Related]
9. Glycolytic inhibition with 3-bromopyruvate suppresses tumor growth and improves survival in a murine model of anaplastic thyroid cancer.
Zhao B; Aggarwal A; Marshall JA; Barletta JA; Kijewski MF; Lorch JH; Nehs MA
Surgery; 2022 Jan; 171(1):227-234. PubMed ID: 34334212
[TBL] [Abstract][Full Text] [Related]
10. Optimal combination of treatment modality to increase survival in patients with anaplastic thyroid carcinoma: A STROBE compliant retrospective study.
Lee JH; Ahn HK; Seok JY; Lee KC; Chun YS; Chung YS; Lee YD
Medicine (Baltimore); 2018 Jun; 97(25):e11037. PubMed ID: 29923991
[TBL] [Abstract][Full Text] [Related]
11. Anaplastic thyroid carcinoma: a 25-year single-institution experience.
Mohebati A; Dilorenzo M; Palmer F; Patel SG; Pfister D; Lee N; Tuttle RM; Shaha AR; Shah JP; Ganly I
Ann Surg Oncol; 2014 May; 21(5):1665-70. PubMed ID: 24554064
[TBL] [Abstract][Full Text] [Related]
12. Combining doxorubicin-nanobubbles and shockwaves for anaplastic thyroid cancer treatment: preclinical study in a xenograft mouse model.
Marano F; Frairia R; Rinella L; Argenziano M; Bussolati B; Grange C; Mastrocola R; Castellano I; Berta L; Cavalli R; Catalano MG
Endocr Relat Cancer; 2017 Jun; 24(6):275-286. PubMed ID: 28487350
[TBL] [Abstract][Full Text] [Related]
13. Anaplastic thyroid cancer: the addition of systemic chemotherapy to radiotherapy led to an observed improvement in survival--a single centre experience and review of the literature.
Lowe NM; Loughran S; Slevin NJ; Yap BK
ScientificWorldJournal; 2014; 2014():674583. PubMed ID: 25184150
[TBL] [Abstract][Full Text] [Related]
14. Anaplastic Thyroid Cancer: New Horizons and Challenges.
Maniakas A; Zafereo M; Cabanillas ME
Endocrinol Metab Clin North Am; 2022 Jun; 51(2):391-401. PubMed ID: 35662448
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of multimodal therapy in a large series of patients with anaplastic thyroid cancer.
Fan D; Ma J; Bell AC; Groen AH; Olsen KS; Lok BH; Leeman JE; Anderson E; Riaz N; McBride S; Ganly I; Shaha AR; Sherman EJ; Tsai CJ; Kang JJ; Lee NY
Cancer; 2020 Jan; 126(2):444-452. PubMed ID: 31593317
[TBL] [Abstract][Full Text] [Related]
16. CAR T Therapy Targeting ICAM-1 Eliminates Advanced Human Thyroid Tumors.
Min IM; Shevlin E; Vedvyas Y; Zaman M; Wyrwas B; Scognamiglio T; Moore MD; Wang W; Park S; Park S; Panjwani S; Gray KD; Tassler AB; Zarnegar R; Fahey TJ; Jin MM
Clin Cancer Res; 2017 Dec; 23(24):7569-7583. PubMed ID: 29025766
[No Abstract] [Full Text] [Related]
17. Anaplastic Thyroid Carcinoma: Current Issues in Genomics and Therapeutics.
Abe I; Lam AK
Curr Oncol Rep; 2021 Feb; 23(3):31. PubMed ID: 33582932
[TBL] [Abstract][Full Text] [Related]
18. Changes of Clinicopathologic Characteristics and Survival Outcomes of Anaplastic and Poorly Differentiated Thyroid Carcinoma.
Lee DY; Won JK; Lee SH; Park DJ; Jung KC; Sung MW; Wu HG; Kim KH; Park YJ; Hah JH
Thyroid; 2016 Mar; 26(3):404-13. PubMed ID: 26541309
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of combined treatment for anaplastic thyroid carcinoma: results of a multinstitutional retrospective analysis.
Conzo G; Polistena A; Calò PG; Bononi P; Gambardella C; Mauriello C; Tartaglia E; Avenia S; Sanguinetti A; Medas F; de Toma G; Avenia N
Int J Surg; 2014; 12 Suppl 1():S178-82. PubMed ID: 24866070
[TBL] [Abstract][Full Text] [Related]
20. Single agent nanoparticle for radiotherapy and radio-photothermal therapy in anaplastic thyroid cancer.
Zhou M; Chen Y; Adachi M; Wen X; Erwin B; Mawlawi O; Lai SY; Li C
Biomaterials; 2015 Jul; 57():41-9. PubMed ID: 25913249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
